These findings establish a regulatory relationship between AR and ZFHX3, suggest a role of ZFHX3 in AR function and implicate ZFHX3 loss in the antiandrogen therapies of PCa. This evidence concerns the gene ZFHX3 and posterior cortical atrophy.